These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10671065)

  • 61. Characterization of a novel mucopolysaccharidosis type II mouse model and recombinant AAV2/8 vector-mediated gene therapy.
    Jung SC; Park ES; Choi EN; Kim CH; Kim SJ; Jin DK
    Mol Cells; 2010 Jul; 30(1):13-8. PubMed ID: 20652491
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Detection of a new mutation (T1140C)in a Chinese Guangdong patient with hunter syndrome].
    Guo YB; Du CS
    Yi Chuan; 2006 May; 28(5):521-4. PubMed ID: 16735228
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A novel mutation of IDS gene in a Chinese patient with mucopolysaccharidosis II by next-generation sequencing.
    Wei X; Jin F; Ye Y; Xu C; Qu N; Ju X; Yi X
    Clin Chim Acta; 2011 Nov; 412(23-24):2340-2. PubMed ID: 21910981
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis.
    Sukegawa-Hayasaka K; Kato Z; Nakamura H; Tomatsu S; Fukao T; Kuwata K; Orii T; Kondo N
    J Inherit Metab Dis; 2006 Dec; 29(6):755-61. PubMed ID: 17091340
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sequence of the human iduronate 2-sulfatase (IDS) gene.
    Wilson PJ; Meaney CA; Hopwood JJ; Morris CP
    Genomics; 1993 Sep; 17(3):773-5. PubMed ID: 8244397
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessment of iduronate-2-sulfatase mRNA expression in Hunter syndrome (mucopolysaccharidosis type II).
    Crotty PL; Whitley CB
    Hum Genet; 1992 Nov; 90(3):285-8. PubMed ID: 1283150
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mutations in the iduronate-2-sulfatase gene in 12 Spanish patients with Hunter disease.
    Gort L; Coll MJ; Chabás A
    Hum Mutat; 1998; Suppl 1():S66-8. PubMed ID: 9452044
    [No Abstract]   [Full Text] [Related]  

  • 68. Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene.
    Hopwood JJ; Bunge S; Morris CP; Wilson PJ; Steglich C; Beck M; Schwinger E; Gal A
    Hum Mutat; 1993; 2(6):435-42. PubMed ID: 8111411
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome.
    Bondeson ML; Dahl N; Malmgren H; Kleijer WJ; Tönnesen T; Carlberg BM; Pettersson U
    Hum Mol Genet; 1995 Apr; 4(4):615-21. PubMed ID: 7633410
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Two distinct deletions in the IDS gene and the gene W: a novel type of mutation associated with the Hunter syndrome.
    Karsten SL; Lagerstedt K; Carlberg BM; Kleijer WJ; Zaremba J; Van Diggelen OP; Czartoryska B; Pettersson U; Bondeson ML
    Genomics; 1997 Jul; 43(2):123-9. PubMed ID: 9244428
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The iduronate sulfatase gene: isolation of a 1.2-Mb YAC contig spanning the entire gene and identification of heterogeneous deletions in patients with Hunter syndrome.
    Palmieri G; Capra V; Romano G; D'Urso M; Johnson S; Schlessinger D; Morris P; Hopwood J; Di Natale P; Gatti R; Ballabio A
    Genomics; 1992 Jan; 12(1):52-7. PubMed ID: 1733863
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enigmatic in vivo iduronate-2-sulfatase (IDS) mutant transcript correction to wild-type in Hunter syndrome.
    Lualdi S; Tappino B; Di Duca M; Dardis A; Anderson CJ; Biassoni R; Thompson PW; Corsolini F; Di Rocco M; Bembi B; Regis S; Cooper DN; Filocamo M
    Hum Mutat; 2010 Apr; 31(4):E1261-85. PubMed ID: 20104590
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Analysis of IDS gene mutation in a family affected with mucopolysaccharidosis typeⅡ].
    Li Y; Mei S; Kong X; Zhao Z; Zhu X; Yang X; Qin Z; Wu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):58-60. PubMed ID: 28186595
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intermediate form of mucopolysaccharidosis type II (Hunter disease): a C1327 to T substitution in the iduronate sulfatase gene.
    Sukegawa K; Tomatsu S; Tamai K; Ikeda M; Sasaki T; Masue M; Fukuda S; Yamada Y; Orii T
    Biochem Biophys Res Commun; 1992 Mar; 183(2):809-13. PubMed ID: 1550586
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reassessment of biochemically determined Hunter syndrome carrier status by DNA testing.
    Timms KM; Edwards FJ; Belmont JW; Yates JR; Gibbs RA
    J Med Genet; 1998 Aug; 35(8):646-9. PubMed ID: 9719370
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mutation analysis in 57 unrelated patients with MPS II (Hunter's disease).
    Vafiadaki E; Cooper A; Heptinstall LE; Hatton CE; Thornley M; Wraith JE
    Arch Dis Child; 1998 Sep; 79(3):237-41. PubMed ID: 9875019
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of an alternative transcript from the human iduronate-2-sulfatase (IDS) gene.
    Malmgren H; Carlberg BM; Pettersson U; Bondeson ML
    Genomics; 1995 Sep; 29(1):291-3. PubMed ID: 8530090
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The mutational spectrum of hunter syndrome reveals correlation between biochemical and clinical profiles in Tunisian patients.
    Chkioua L; Grissa O; Leban N; Gribaa M; Boudabous H; Turkia HB; Ferchichi S; Tebib N; Laradi S
    BMC Med Genet; 2020 May; 21(1):111. PubMed ID: 32448126
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mucopolysaccharidosis type II (Hunter disease): identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patients.
    Sukegawa K; Tomatsu S; Fukao T; Iwata H; Song XQ; Yamada Y; Fukuda S; Isogai K; Orii T
    Hum Mutat; 1995; 6(2):136-43. PubMed ID: 7581397
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel fluorometric enzyme analysis method for Hunter syndrome using dried blood spots.
    Tolun AA; Graham C; Shi Q; Sista RS; Wang T; Eckhardt AE; Pamula VK; Millington DS; Bali DS
    Mol Genet Metab; 2012 Mar; 105(3):519-21. PubMed ID: 22227323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.